Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00662402 · ClinicalTrials.gov registry record · NA
Impact of Extensive Consultation on Career Development Grant Outcomes
A NA study of Career Development Grant Outcomes, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT00662402: Completed NA study of Career Development Grant Outcomes, sponsored by University of California, San Francisco.
NCT00662402 is a NA study of Career Development Grant Outcomes that has completed, run by University of California, San Francisco. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00662402, a NA study of Career Development Grant Outcomes, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study we wish is to determine whether extensive (up to 15 hours) multidisciplinary consultation in biostatistics, study design, data management, ethics, and writing provided by the UCSF Clinical and Translational Science Institute's (CTSI) Consultation Services program, improves peer review scores of career development grants compared to usual levels of consultation. We hypothesize that extensive multidisciplinary consultation will improve peer review scores of career development grants compared to usual levels of consultation. We hypothesize that extensive multidisciplinary consultation will lead to greater numbers of funded grants when compared to the usual levels of consultation.
Conditions Studied
Interventions
- OTHER Extensive Consultations
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2008-04 |
| Est. Completion | 2018-07-30 |
| Phase | NA |
What the finished NCT00662402 record still lists
NCT00662402 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Career Development Grant Outcomes appearing as the primary indexed condition, and to 1 intervention - of which Extensive Consultations is the first listed.
NCT00662402 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00662402 about?
NCT00662402 is a clinical study titled "Impact of Extensive Consultation on Career Development Grant Outcomes". In this study we wish is to determine whether extensive (up to 15 hours) multidisciplinary consultation in biostatistics, study design, data management, ethics, and writing provided by the UCSF Clinical and Translational Science Institute's (CTSI) Consultation Services program, improves peer review ...
What is the current status of trial NCT00662402?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2008-04. Estimated completion is 2018-07-30.
What conditions does trial NCT00662402 study?
This clinical trial studies the following conditions: Career Development Grant Outcomes.
What interventions are being tested in trial NCT00662402?
The interventions under investigation include: Extensive Consultations (OTHER).
Who is sponsoring clinical trial NCT00662402?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00662402 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00662402's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia